ArticleOncology letters2011

Soluble VEGF receptor-2 may be a predictive marker of anti-angiogenic therapy with clinically available safe agents.

Hitoshi Yoshiji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.